BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 2687687)

  • 1. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families.
    Hayden FG; Belshe RB; Clover RD; Hay AJ; Oakes MG; Soo W
    N Engl J Med; 1989 Dec; 321(25):1696-702. PubMed ID: 2687687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ;
    N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.
    Dolin R; Reichman RC; Madore HP; Maynard R; Linton PN; Webber-Jones J
    N Engl J Med; 1982 Sep; 307(10):580-4. PubMed ID: 7050702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children with influenza A infection: treatment with rimantadine.
    Hall CB; Dolin R; Gala CL; Markovitz DM; Zhang YQ; Madore PH; Disney FA; Talpey WB; Green JL; Francis AB
    Pediatrics; 1987 Aug; 80(2):275-82. PubMed ID: 3302925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use.
    Houck P; Hemphill M; LaCroix S; Hirsh D; Cox N
    Arch Intern Med; 1995 Mar; 155(5):533-7. PubMed ID: 7864709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of rimantadine prophylaxis of children within families.
    Clover RD; Crawford SA; Abell TD; Ramsey CN; Glezen WP; Couch RB
    Am J Dis Child; 1986 Jul; 140(7):706-9. PubMed ID: 3521258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of rimantadine resistance in field isolates of influenza A viruses.
    Ziegler T; Hemphill ML; Ziegler ML; Perez-Oronoz G; Klimov AI; Hampson AW; Regnery HL; Cox NJ
    J Infect Dis; 1999 Oct; 180(4):935-9. PubMed ID: 10479115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amantadine and rimantadine for the prevention of influenza A.
    Betts RF
    Semin Respir Infect; 1989 Dec; 4(4):304-10. PubMed ID: 2697053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of rimantadine-resistant virus within 6 days of starting rimantadine prophylaxis with oseltamivir treatment of symptomatic cases.
    Drinka PJ; Haupt T
    J Am Geriatr Soc; 2007 Jun; 55(6):923-6. PubMed ID: 17537095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults.
    Hayden FG; Monto AS
    Antimicrob Agents Chemother; 1986 Feb; 29(2):339-41. PubMed ID: 3521480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.
    Monto AS; Pichichero ME; Blanckenberg SJ; Ruuskanen O; Cooper C; Fleming DM; Kerr C
    J Infect Dis; 2002 Dec; 186(11):1582-8. PubMed ID: 12447733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rimantadine prophylaxis in children: a follow-up study.
    Crawford SA; Clover RD; Abell TD; Ramsey CN; Glezen P; Couch RB
    Pediatr Infect Dis J; 1988 Jun; 7(6):379-83. PubMed ID: 3292997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic.
    Heider H; Adamczyk B; Presber HW; Schroeder C; Feldblum R; Indulen MK
    Acta Virol; 1981 Nov; 25(6):395-400. PubMed ID: 6120642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine.
    Hayden FG; Sperber SJ; Belshe RB; Clover RD; Hay AJ; Pyke S
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1741-7. PubMed ID: 1952841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in children.
    Thompson J; Fleet W; Lawrence E; Pierce E; Morris L; Wright P
    J Med Virol; 1987 Mar; 21(3):249-55. PubMed ID: 3549971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance.
    Belshe RB; Burk B; Newman F; Cerruti RL; Sim IS
    J Infect Dis; 1989 Mar; 159(3):430-5. PubMed ID: 2915166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virion transcriptase activity of rimantadine-sensitive and rimantadine-resistant variants of human influenza virus.
    Indulen MK; Kalninya VA; Gorodkova NV; Akopova II; Ghendon YuZ
    Acta Virol; 1987 Nov; 31(6):458-62. PubMed ID: 2894138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.
    Hayden FG; Belshe R; Villanueva C; Lanno R; Hughes C; Small I; Dutkowski R; Ward P; Carr J
    J Infect Dis; 2004 Feb; 189(3):440-9. PubMed ID: 14745701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the inhibitory effect of rimantadine on the reproduction of epidemic strains of influenza A virus H3N2 and H1N1.
    Pushkarskaya NL; Lvov ND; Kochemasova ZN
    Acta Virol; 1981 Sep; 25(5):319-21. PubMed ID: 6118052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.